Laughing Water Capital highlights Theravance Biopharma as a special situation with significant upside potential. Read the ...
Laughing Water Capital returned -4.5% in Q1 2026 while highlighting new high-conviction positions in Stride and Theravance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results